HC Wainwright Brokers Lower Earnings Estimates for EPRX

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX – Free Report) – Research analysts at HC Wainwright decreased their Q3 2025 EPS estimates for shares of Eupraxia Pharmaceuticals in a research note issued on Wednesday, August 13th. HC Wainwright analyst B. Folkes now expects that the company will post earnings per share of ($0.20) for the quarter, down from […]

Leave a Reply

Your email address will not be published.

Previous post William Blair Analysts Lift Earnings Estimates for Harrow
Next post Zacks Research Expects Stronger Earnings for Harley-Davidson